Clinical Trials on Prostatic Hyperplasia in United States
Total 4265 results
-
University of FloridaCompleted
-
University of Alabama at BirminghamSanofi; Astellas Pharma IncWithdrawn
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)CompletedMetastatic Prostate CancerUnited States
-
Baylor College of MedicineCompletedLocalized Prostate CancerUnited States
-
University of Colorado, DenverCompletedProstate Cancer ScreeningUnited States
-
Lahey ClinicTerminated
-
University of Southern CaliforniaNational Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Hormone-resistant Prostate CancerUnited States
-
University of WashingtonNational Cancer Institute (NCI)WithdrawnRecurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Stage IV Prostate CancerUnited States
-
Castleman Disease Collaborative NetworkWithdrawnHyperplasia | Castleman Disease | Castleman's Disease | Giant Lymph Node Hyperplasia | Angiofollicular Lymph Hyperplasia | Angiofollicular Lymph Node Hyperplasia | Angiofollicular Lymphoid Hyperplasia | GLNH | Giant Lymph NodeUnited States
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Stage I Prostate Cancer | Stage III Prostate Cancer | Adenocarcinoma of the Prostate | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
Io TherapeuticsCompletedCastration Resistant Prostate CancerUnited States
-
Won KimNovartisTerminated
-
NanOlogy, LLCUS Biotest, Inc.CompletedAdenocarcinoma of the ProstateUnited States
-
Medical University of South CarolinaNational Cancer Institute (NCI)Completed
-
University of Southern CaliforniaNational Cancer Institute (NCI)WithdrawnProstate Cancer Stage I AJCC V6 | Prostate Cancer Stage II | Prostate Cancer Stage IIIUnited States
-
Memorial Sloan Kettering Cancer CenterMillennium Pharmaceuticals, Inc.CompletedMetastatic Castration-Resistant Prostate CancerUnited States
-
Bellicum PharmaceuticalsM.D. Anderson Cancer Center; The University of Texas Health Science Center,... and other collaboratorsCompletedCastrate Resistant Prostate Cancer (CRPC)United States
-
Astellas Pharma Global Development, Inc.Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedMetastatic Castration-Resistant Prostate CancerUnited States
-
National Cancer Institute (NCI)CompletedProstate Cancer | Metastatic Castrate Resistant Prostate CancerUnited States
-
National Cancer Institute (NCI)M.D. Anderson Cancer CenterCompletedStage II Prostate Cancer | Adenocarcinoma of the ProstateUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Stage I Prostate Cancer | Adenocarcinoma of the Prostate | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Bone Metastases | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
University of UtahGenentech, Inc.; Bavarian NordicWithdrawnProstate AdenocarcinomaUnited States
-
Tufts UniversityCompletedProstate NeoplasmUnited States
-
National Cancer Institute (NCI)RecruitingProstatic Neoplasms | Prostate Cancer | Metastatic Prostate Cancer | Cancer Of Prostate | ProstateUnited States
-
Sharp HealthCareWithdrawnMetastatic Prostate CancerUnited States
-
OHSU Knight Cancer InstituteBristol-Myers Squibb; Oregon Health and Science UniversityCompletedRecurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
Tulane UniversityBlue Earth DiagnosticsCompletedMetastatic Castration-resistant Prostate CancerUnited States
-
Duke UniversityExelixisTerminatedProstate Cancer | Prostate Cancer Adenocarcinoma | Non-MetastaticUnited States
-
Georgetown UniversityTerminatedStage II Prostate CarcinomaUnited States
-
Queen's Medical CenterNational Cancer Institute (NCI); National Institutes of Health (NIH)CompletedHormone Refractory Prostate CancerUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedCancer | Prostate | Hormonal CyclingUnited States
-
University of ChicagoVisualase, Inc.Completed
-
GenVecNational Institutes of Health (NIH)UnknownLocally Advanced Prostate CancerUnited States
-
NanOlogy, LLCUS Biotest, Inc.TerminatedUrogenital Neoplasms | Genital Neoplasms, Male | Prostate Cancer | Prostate Adenocarcinoma | Prostatic Neoplasm | Localized Cancer | Prostate Cancer AdenocarcinomaUnited States
-
Cougar Biotechnology, Inc.CompletedProstate Cancer | Prostate NeoplasmsUnited States
-
Massachusetts General HospitalCompletedProstate AdenocarcinomaUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
Prostate Oncology Specialists, Inc.CompletedProstate Cancer | Castrate Resistant Prostate CancerUnited States
-
National Cancer Institute (NCI)CompletedProstate Adenocarcinoma | Recurrent Prostate Carcinoma | Stage IV Prostate Cancer | Hormone-Resistant Prostate CancerUnited States
-
University of ChicagoNational Cancer Institute (NCI)CompletedCastration-resistant Prostate Cancer | Stage IV Prostate CancerSingapore, United States
-
David M LubaroffUnited States Department of DefenseCompletedHormone Refractory Prostate CancerUnited States
-
Duke UniversityUnited States Department of DefenseCompletedMetastatic Hormone Refractory Prostate CancerUnited States
-
The University of Texas Health Science Center at...WithdrawnMetastatic Prostate Cancer | Prostate Cancer Metastatic | Metastatic Prostate Adenocarcinoma | Castrate Resistant Prostate CancerUnited States
-
Timothy HoffmanUniversity of Missouri-Columbia; Harry S. Truman Memorial Veterans' Hospital; Telix Pharmaceuticals, LtdTerminatedProstate Cancer | Prostate AdenocarcinomaUnited States
-
University of Texas Southwestern Medical CenterCompletedmCRPC | Metastatic Castrate-resistant Prostate CancerUnited States
-
Cancer Center of IrvineUnknown
-
GenesisCare USADendreonCompletedCastrate Refractory Metastatic Prostate Cancer (mCRPC)United States
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedMetastatic Progressive Castration-resistant Prostate CancerUnited States
-
National Cancer Institute (NCI)Completed